Former Expedia VP & AI Labs Director & Entrepreneurial Star Dr. Fang's Entrepreneurial Journey
Time & Location
Jun 28, 2024, 6:30 PM – 8:30 PM PDT
Bellevue, 3600 136th Pl SE Suite 300, Bellevue, WA 98006, USA
About the Event
Guest Introduction
Dr. Luyuan Fang, CEO and Co-founder of CurativeAI. Prior to joining CurativeAI, Luyuan built three top AI and data teams and successfully implemented AI, LLM, data platform and solution products in three verticals on a large scale.
- Healthcare: served as Chief AI Officer of Change Healthcare (now UnitedHealthcare / Optum Insight).
- Prescription drug market: served as Chief AI and Data Officer of Prescryptive Health.
- Online travel market: served as Vice President of Expedia Group, founder and leader of AI Labs.
Dr. Fang has worked at eBay, Microsoft Azure, Cisco Systems, and AT&T. She has a PhD in Computer Science (AI, Neural Networks), 10 US patents, and has written more than 100 articles and speeches. She has delivered keynote speeches and served as chair at global AI and network conferences. Luyuan is a board member of three healthcare AI startups.
CurativeAI Introduction
CurativeAI is a Seattle-based healthcare AI startup whose mission is to leverage AI and data to redefine the operation and delivery of healthcare systems, improve patient outcomes, assist healthcare providers with AI clinical decision support, push the boundaries of precision medicine, and provide AI-First RCM solutions to optimize the efficiency and effectiveness of healthcare workflows throughout the patient journey. With strong financial support, we are still in the early stages and already have our first batch of customers. If you are as passionate as we are about transforming healthcare with the power of "AI First", welcome to join our exciting journey. We are hiring!
Event Content
1. Dr. Fang's career advancement experience;
2. How to lead a team so that every team member has the opportunity to grow;
3. Competition and cooperation, so that every project can be successful;
4. CurativeAI introduction and prospects.